Hedia logo — Our vision is to improve quality of life for people with dia...

Hedia

Our vision is to improve quality of life for people with diabetes and make the best diabetes management tools available.

Founded 2015 Denmark Denmark 43 employees Seed Total: $35.07M AI, Life Sciences +1

General Information

Company Name Hedia
Founded Year 2015
Location Denmark Denmark
Employees 43
Industries AI, Life Sciences, Medical Devices
Funding Stage Seed

BounceWatch is an independent company data service, not affiliated with Hedia. To contact Hedia, visit hedia.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Hedia compare?

A PDF of Hedia and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Hedia soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Hedia

Hedia is a Danish startup with a vision to improve the quality of life for people with diabetes by making the best diabetes management tools accessible to a wider audience. Their flagship product, the Hedia Diabetes Assistant (HDA), is a class IIb medical device designed to enhance the management of insulin-requiring diabetes and stabilize blood glucose levels. By analyzing individual habits and personalized input, HDA provides tailored insulin recommendations, thus assisting individuals with their treatment. In addition to their diabetes management tool, Hedia also offers an education platform for healthcare professionals. Founded in 2015, Hedia operates in the fields of AI, Life Sciences, and Medical Devices. Their recent milestone includes a kr22.50M Seed Round investment on 23 February 2024. Although the specific investors for this round are not mentioned, the company has developed its platform in close collaboration with patients, nurses, and other key stakeholders to ensure a fit for living with diabetes. Hedia's vision and strategic positioning in the healthcare industry make it a promising contender in the diabetes management landscape.

Business keywords: Diabetes Management, Medical Device, Healthcare Professionals Education, Insulin Recommendations, Patient-Centric Solution, Personalized Healthcare, Chronic Disease Management, AI-Powered Healthcare, Patient Engagement, Healthcare Innovation

Services & Products

Development and distribution of the Hedia Diabetes Assistant
a class IIb medical device designed to support the management of insulin-requiring diabetes. Additionally
collaboration with partners in the diabetes ecosystem.

Target Customers

Patients with insulin-requiring diabetes healthcare professionals clinics hospitals and industry leaders within the diabetes care space.

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round kr22.50M -
23 Feb 2024
Seed Round €3.00M -
23 Dec 2021
Seed Round €1.50M -
01 Nov 2020
Seed Round €2.00M -
01 Jul 2019
Grant €71.43K 1
EASME - EU Executive Agency for SMEs
01 Jan 2019
Seed Round kr5.50M 1
Startupbootcamp Digital Health Berlin
15 Jun 2018
Convertible Note kr500.00K 1
PreSeed Ventures
21 Oct 2016

Hedia Alternatives & Competitors

View All Alternatives
Hedia vs
Bigfoot Biomedical
Bigfoot Biomedical United States

A Simple Way To Manage Diabetes

Convertible Note
80 employees
AI, Analytics
Hedia vs

Fun despite diabetes .. we help people with diabetes who have difficulties finding the correct insul...

Seed
1 employees
AI, Health Care
Hedia vs

Prevention as a Service™

Seed
11 employees
AI, Biotechnology

FAQ About Hedia

Our vision is to improve quality of life for people with diabetes and make the best diabetes management tools available.
Hedia was founded in 2015.
Hedia is headquartered in Denmark.
Hedia operates in AI, Life Sciences and Medical Devices. Its work centres on Diabetes Management, Medical Device, Healthcare Professionals Education and Insulin Recommendations. Its customers include Patients with insulin-requiring diabetes, healthcare professionals and clinics.
Hedia has approximately 43 employees.
Hedia has completed 7 funding rounds, raising a total of $35.07M. The latest funding stage is Seed.
Hedia offers: Development and distribution of the Hedia Diabetes Assistant, a class IIb medical device designed to support the management of insulin-requiring diabetes. Additionally, collaboration with partners in the diabetes ecosystem..
Top alternatives and competitors to Hedia include Bigfoot Biomedical, diafyt Medtech, Bio Conscious Technologies Inc., Aktiia, Labplus. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Hedia and Bigfoot Biomedical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Hedia, https://bouncewatch.com/company/hedia, updated 24 February 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes